Informazioni sul prodotto
3-Oxa-7-azabicyclo[3.3.1]nonan-9-ol is a compound that has been shown to lower blood glucose levels in animal models and has potent oral efficacy, as well as agonistic activity at the GLP-1 receptor. It is currently in phase II clinical trials for the treatment of type 2 diabetes. 3-Oxa-7-azabicyclo[3.3.1]nonan-9-ol is an orally active compound that lowers glucose levels by stimulating insulin secretion and enhancing insulin sensitivity in liver cells. It has been shown to have a conformationally restricted agonist activity at the GLP-1 receptor, which may be due to its structural similarity to octane, a ligand for this receptor
Proprietà chimiche
Richiesta tecnica su: 3D-WZB18779 3-Oxa-7-azabicyclo[3.3.1]nonan-9-ol
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.